FeaturesSignalPricingFounders
Log inGet started free
CV

Clarus Ventures

Venture CapitalActive

Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.

Cambridge, United StatesFounded 2003clarusfunds.com
85
Investments
9
Exits
$3B
AUM
10.6%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Clarus Ventures.

Get started free

Investment Thesis & Strategy

Clarus Ventures invests in various stages of biotech and healthcare companies, seeking to support innovative ventures within the healthcare sector.

Investment Activity

Deals per year over the last 8 years

2
2003
0
2004
1
2005
1
2006
1
2007
3
2008
0
2009
1
2010

Portfolio Companies

Selected investments from their portfolio of 85 companies

R
Regeneron Pharmaceuticals
Biotech · Series A, 0
Active
M
Millennium Pharmaceuticals
Biotech · Series A, 0
Active
A
ARIAD Pharmaceuticals
Biotech · Series A, 0
Active
R
Radius Health
Biotech · Series A, 2010
Active
C
Catabasis Pharmaceuticals
Biotech · Series A, 2008
Active
E
Esperion Therapeutics
Biotech · Series A, 2008
Active
T
Tetraphase Pharmaceuticals
Biotech · Series A, 2008
Active
E
Epizyme
Biotech · Series A, 2007
Active
P
Portola Pharmaceuticals
Biotech · Series A, 2006
Active
A
Achillion Pharmaceuticals
Biotech · Series A, 2005
Active
A
Acceleron Pharma
Biotech · Series A, 2003
Active
I
Ironwood Pharmaceuticals
Biotech · Series A, 2003
Active

Notable Exits

CompanyTypeYearValue / Acquirer
SequenomAcquisition2016$470M
PharmacyclicsAcquisition2015$21B
Idenix PharmaceuticalsAcquisition2014$3.8B
Aragon PharmaceuticalsAcquisition2013$1B
Portola PharmaceuticalsIPO2013$1.1B
Syntonix PharmaceuticalsAcquisition2011$120M
Millennium PharmaceuticalsAcquisition2008$8.9B
Sirtris PharmaceuticalsAcquisition2008$720M
Seattle GeneticsIPO2001$100M

Frequently Asked Questions

Clarus Ventures focuses on Series A, Series B, Series C+ stage investments.

Related Investors